Skip to main content

Table 1 Clinical features of patients with FKRP mutations

From: LGMD2I in a North American population

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7

Gender

Male

Male

Female

Male

Female

Female

Male

Ethnicity

-

Causasian

Caucasian

Caucasian

Caucasian

Caucasian

Asian

Onset

34 months

1st grade

18–19 years

Childhood

23 years

Childhood

25 years

Chief complaint

Difficulty rising

Difficulty running

Exertional myalgias

Difficulty running

Difficulty with stairs

Difficulty running

Difficulty with stairs

Calf pseudohypertrophy

Present

-

None

Present

None

Present

Medial calf atrophy

Heel cords

Contracted

-

Normal

Unknown

Contracted

Normal

-

Facial strength

Normal

Mild weakness

Normal

Normal

Normal

Normal

Normal

Scapular winging

-

-

-

-

Subtle

Subtle

Subtle

Proximal upper extremity strength

-

4+

4-

5

4-

4

4+

Distal upper extremity strength

-

5

5

5

4+ to 5

4+

5

Proximal lower extremity strength

Weak

2+ to 3+

3- to 4-

2 to 3

2

3- to 3

3- to 4-

Distal lower extremity strength

-

5

5

5

4

4

5- to 5

Reflexes

2+

Trace

2+

1+ to 2+

1+ to 2+

2+

2+

FVC (% predicted)

-

-

-

-

2.72L (83%)

2.87L (75%)

3.03L (56%)

Echocardiogram (ejection fraction)

Normal

-

Normal (55%)

Angiogram normal

Normal (>55%)

~45%

(>55%)

Creatine kinase (U/L)

5,438

5,000+

1,945

3–4 times normal

1,136

5,031

6,560 to 10,642

Dystrophin duplication/deletion

None

-

None

None

-

-

-

Age at biopsy

3 1/2 years

17 years

30 years

51 years

27 years

25 years

-

Muscle sampled

Left quadriceps

Left biceps

Deltoid

Left quadriceps

Biceps

Deltoid

-

Dystrophin staining

Normal

Normal

Normal

Normal

Normal

Normal

-

Merosin staining

Normal

-

-

-

-

Decreased

-

Sarcoglycans (α,β,γ,δ)

Normal

Normal

Normal

-

Normal

Normal

-

β-dystroglycan

Normal

-

Normal

-

Normal

Normal

-

Spectrin

-

Normal

Normal

-

Normal

Normal

-

FKRP mutation

c.826C>A, p.L276I (homozygous)

c.826C>A, p.L276I (homozygous)

c.826C>A, p.L276I (homozygous)

c.826C>A, p.L276I (homozygous)

c.826C>A, p.L276I (homozygous)

c.826C>A, p.L276I (homozygous)

del 1006–1174 (169 basepair frameshift, heterozygous), c.328C>T, p.R110W (heterozygous)

  1. -, not done or not assessed; FVC, forced vital capacity; extremity strength graded on Medical Research Council (MRC) scale